Posts by Constance D. Lehman, MD, PhD
-
Deep Learning Model Outperforms Traditional Models for Predicting Breast Cancer in Women at High Risk
Leslie R. Lamb, MD, MSc, Constance D. Lehman, MD, PhD, and colleagues have demonstrated that a mammogram-based deep learning risk stratification model is more likely than traditional breast cancer risk models to identify women who will benefit from supplemental screening with breast MRI.
-
Pragmatic Approach to Managing and Interpreting Breast Imaging After COVID-19 Vaccination
Constance D. Lehman, MD, PhD, Leslie R. Lamb, MD, MSc, and Helen Anne D'Alessandro, MD, of the Department of Radiology, explain their department's approach to managing unilateral axillary adenopathy detected incidentally on breast imaging after COVID-19 vaccination.
-
Digital Breast Tomosynthesis Superior to Mammography for Surveillance of Breast Cancer Survivors
Manisha Bahl, MD, MPH, and Constance D. Lehman, MD, PhD, of the Department of Radiology, and colleagues found that, among breast cancer survivors, digital breast tomosynthesis was associated with a lower abnormal interpretation rate and higher specificity than conventional mammography.
-
Editorial: Radiologists Have Opportunities to Improve Patient Engagement in Mammographic Screening
Radiologists should emphasize areas of broad consensus about the benefits of screening mammography when speaking with patients, referring providers and administrators.
-
The Role of Radiology in Identifying Intimate Partner Violence
Radiologists can play an important role in identifying cases of IPV and helping ensure patients receive the help they need, even when they are seeking care for unrelated reasons.
Biography
Constance “Connie” Lehman, MD, PhD, is professor of Radiology at Harvard Medical School, and the Director of Breast Imaging, and Co-Director of the Avon Comprehensive Breast Evaluation Center at the Massachusetts General Hospital in Boston, Massachusetts. Dr. Lehman received her undergraduate education at Duke University and her MD and PhD at Yale University. Dr. Lehman serves on several key national committees including the National Cancer Institute’s Breast Cancer Steering Committee and the American College of Radiology’s (ACR) Committee on Breast Imaging for Appropriateness Criteria and Guidelines.
Dr. Lehman has co-authored breast cancer screening recommendations by the American Cancer Society, the ACR and the National Comprehensive Cancer Network. She has authored or co-authored over 200 peer-reviewed scientific publications. Dr. Lehman has served as principal investigator or co-investigator on numerous single and multi-institution clinical trials in breast MRI, mammography and ultrasound, including the ACRIN NEJM publication that reported adding MRI scans to examinations of women with breast cancer improves detection of a second cancer in the opposite breast. She is currently developing and evaluating new methods of deep learning to improve breast cancer detection, diagnosis and treatment. Collectively, her philosophy embodies the notion that we improve the health of our community by delivery the highest quality patient-centered care in a setting of active innovation and education.
Mass General Imaging
For over 100 years, the Department of Radiology at Massachusetts General Hospital has pioneered imaging technology to improve human health. Today, our researchers develop powerful new ways to diagnose and treat many diseases. From the lab to the clinic, our community of radiologists and researchers brings advances directly to our patients.